Nanologica, a life sciences company that makes silica-based peptides for the pharmaceutical industry, acquired CDMO Ardena’s ...
Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said ...
To stir up support for the fight against cancer, Pfizer has turned to one of the most iconic pep talks of all time. | To stir ...
During the first six months of Maziar Mike Doustdar's tenure as Novo Nordisk's CEO, the company enjoyed a run of positive ...
Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Leal explained how healthcare and pharma marketing combines the “best of both worlds” for her.
A U.K. marketing watchdog has sanctioned Sanofi after ruling its CEO Paul Hudson may have undermined the U.K. government’s ...
Over the last decade-plus, China has become a booming biopharma innovator thanks in part to a big boost from its government. Now the question is, can its neighbor to the south, India, make a similar ...
AstraZeneca has hit what appears to be a minor speed bump in gaining clearance in the U.S. for its subcutaneous (SC) version of lupus treatment Saphnelo. | AstraZeneca will have to negotiate what ...
Ahead of the readouts, BMS and J&J have started an educational push called “Change the Target. Change What’s Possible,” they ...
With Valentine’s Day coming up, AbbVie has love on the brain. Ahead of the holiday, the Big Pharma has unveiled a new ...
The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results